mephenytoin and ethotoin

mephenytoin has been researched along with ethotoin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19906 (66.67)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruno-Blanch, L; Gálvez, J; García-Domenech, R1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
BUTLER, TC3
BUTLER, TC; WADDELL, WJ1
WILLIAMS, CM1
CRAVIOTTO, C1

Reviews

1 review(s) available for mephenytoin and ethotoin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for mephenytoin and ethotoin

ArticleYear
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship

2003
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Quantitative studies of the physiological disposition of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and 5-ethyl-5-phenyl hydantoin (nirvanol).
    The Journal of pharmacology and experimental therapeutics, 1953, Volume: 109, Issue:3

    Topics: Anticonvulsants; Blood; Humans; Hydantoins; Imidazoles; Mephenytoin

1953
A pharmacological comparison of the optical isomers of 5-ethyl-5-phenyl hydantoin (nirvanol) and of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin).
    The Journal of pharmacology and experimental therapeutics, 1954, Volume: 110, Issue:1

    Topics: Anticonvulsants; Hydantoins; Imidazoles; Mephenytoin

1954
The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin.
    The Journal of pharmacology and experimental therapeutics, 1956, Volume: 117, Issue:2

    Topics: Anticonvulsants; Hydantoins; Imidazoles; Mephenytoin

1956
Aplastic anaemia due to 3-methyl-5-phenyl-5-ethyl-hydantoin ("mesantoin").
    Clinical reports, 1960, Volume: 10

    Topics: Anemia; Anemia, Aplastic; Humans; Hydantoins; Mephenytoin

1960
[Experimental ophthalmopathic syndrome in guinea pigs caused by prolonged administration of 3-methyl-5-ethylphenylhydantoin].
    Rivista di anatomia patologica e di oncologia, 1961, Volume: 19

    Topics: Animals; Cataract; Eye Diseases; Guinea Pigs; Hydantoins; Keratitis; Mephenytoin

1961
Metabolic demethylation of 3-methyl-5-ethyl-5-phenyl hydantoin (Mesantoin).
    The Journal of pharmacology and experimental therapeutics, 1952, Volume: 104, Issue:3

    Topics: Anticonvulsants; Hydantoins; Mephenytoin

1952